Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 8887-8894
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8887
Table 2 Antiviral interventions for prevention of hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma
Antiviral interventionsHBV-related HCCHCV-related HCC
IFN: IFN-α+/-[28,29][46]
Pegylated IFN[47]
NAs: Lamivudine[36]
Entecavir[37,38]
Ribavirin[47]
Vaccination[21,22]
Screening of blood product[27][27]